Parallel Bio
Watertown
About Parallel Bio
Parallel Bio develops tools that help in the discovery and development of immunotherapies, to eliminate current barriers and create the fastest path to a drug that works. Parallel Bio's platform combines best-in-class human immune organoids with computational methods to generate unprecedented insights into human health and disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2025)
- Website: parallel.bio
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/parallel-bio-42926 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.